Home
Fairmount Funds Management reported a 14.04% stake in Viridian Therapeutics, Inc.\DE VRDN · 17,201,800 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 14.04%
- Last report
- 15.14% · filed 25/10/27
- Shares held
- 17,201,800 sh
- Class
- Common Stock, $0.01 par value per share
- Event date
- 26/05/11
- Filed
- 26/05/13
14.04% stake · −1.1pp from the last report
- Stake
- 14.04%
- Last report
- 15.14%
- Since last report
- −1.1pp
Viridian Therapeutics, Inc.\DE trades, last 26 weeks
What else happened in Viridian Therapeutics, Inc.\DE around then
Filed or reported within 30 days of the trade day · 04/11~06/10Fairmount Funds Management's other 5% stake reports
- Fairmount Funds Management
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
19.99% stake
9,106,420 sh
19.99% stake
Filed 09/11
- Fairmount Funds Management
5% stakeCrescent Biopharma
5% stakeCrescent Biopharma
CBIO
16.52% stake
6,602,408 sh
16.52% stake
Filed 07/20
- Fairmount Funds Management
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
19.5% stake
14,572,917 sh
19.5% stake
Filed 07/01
- Fairmount Funds Management
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
9.99% stake
9,667,201 sh
9.99% stake
Filed 06/23
- Fairmount Funds Management
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
19.99% stake
14,069,494 sh
19.99% stake
Filed 06/09
